Literature DB >> 24889389

Prognostic role of en-bloc resection and late onset of bone metastasis in patients with bone-seeking carcinomas of the kidney, breast, lung, and prostate: SSG study on 672 operated skeletal metastases.

Maire Ratasvuori1, Rikard Wedin, Bjarne H Hansen, Johnny Keller, Clement Trovik, Olga Zaikova, Peter Bergh, Anders Kalen, Minna Laitinen.   

Abstract

BACKGROUND AND OBJECTIVES: In metastatic disease, decisions regarding potential surgery require reliable data about the patient's survival. In this study, we evaluated different prognostic factors and their impact in four common primary tumors causing bone metastases.
METHODS: Data were acquired from the Scandinavian Sarcoma Group (SSG) metastasis registry. The patients underwent surgery between July 1999 and July 2009. This study included breast, prostate, lung, and kidney cancer cases, with a total of 672 operated non-spinal metastases. Differences in prognostic factors were evaluated using the Kaplan-Meier method with long-rank test. Cox regression multivariate analysis was performed to identify statistically independent prognostic factors.
RESULTS: Significant factors affecting survival were the presence of organ metastases, overall heath status, and disease load. In kidney cancer, en bloc resection of solitary metastases was associated with a significant fourfold longer survival compared to intralesional surgery. Preoperative radiotherapy was associated with higher complication and reoperation rates.
CONCLUSIONS: This data summary is important tool for clinicians to evaluate survival and choose treatment options for patients suffering from metastatic bone disease.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  bone metastases; prognostic factors; surgical treatment

Mesh:

Year:  2014        PMID: 24889389     DOI: 10.1002/jso.23654

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  29 in total

1.  [Surgical treatment of skeletal metastases].

Authors:  T Gösling; M Becker-Schiebe
Journal:  Unfallchirurg       Date:  2015-04       Impact factor: 1.000

2.  CORR Insights®: Use of Compressive Osteointegration Endoprostheses for Massive Bone Loss From Tumor and Failed Arthroplasty: A Viable Option in the Upper Extremity.

Authors:  Patrick J Boland
Journal:  Clin Orthop Relat Res       Date:  2017-04-03       Impact factor: 4.176

Review 3.  [Metastatic disease in long bones : Review of surgical treatment options].

Authors:  Franz Liska; Philipp Schmitz; Norbert Harrasser; Peter Prodinger; Hans Rechl; Rüdiger von Eisenhart-Rothe
Journal:  Unfallchirurg       Date:  2018-01       Impact factor: 1.000

4.  Bone metastases of the hand.

Authors:  G Morris; S Evans; J Stevenson; A Kotecha; M Parry; L Jeys; R Grimer
Journal:  Ann R Coll Surg Engl       Date:  2017-09       Impact factor: 1.891

Review 5.  Treatment for long bone metastases based on a systematic literature review.

Authors:  Costantino Errani; Andreas F Mavrogenis; Luca Cevolani; Silvia Spinelli; Andrea Piccioli; Giulio Maccauro; Nicola Baldini; Davide Donati
Journal:  Eur J Orthop Surg Traumatol       Date:  2016-09-20

6.  En bloc resection and intercalary prosthesis implantation for the treatment of humeral diaphyseal bone metastases.

Authors:  Feifei Pu; Zhicai Zhang; Baichuan Wang; Jianxiang Liu; Zengwu Shao
Journal:  Int Orthop       Date:  2020-10-06       Impact factor: 3.075

Review 7.  Does solitary- and organ-confined metastasectomy really improve survival in advanced urologic malignancies?

Authors:  Senol Tonyali; Sertac Yazici
Journal:  Int Urol Nephrol       Date:  2016-02-03       Impact factor: 2.370

Review 8.  Molecular mechanisms and clinical management of cancer bone metastasis.

Authors:  Manni Wang; Fan Xia; Yuquan Wei; Xiawei Wei
Journal:  Bone Res       Date:  2020-07-29       Impact factor: 13.567

9.  [Perioperative clinical characteristics of patients with pathological fracture of proximal femur].

Authors:  Y P Cui; C Mi; B Wang; Y X Pa; Y F Lin; X D Shi
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2019-10-18

Review 10.  [Differentiated treatment strategies for bone metastases of the extremities].

Authors:  B Rath; M Tingart; F Migliorini; J Eschweiler; R Zureik; J Hardes
Journal:  Orthopade       Date:  2019-09       Impact factor: 1.087

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.